• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素II对人内皮细胞存活信号通路及其血管生成反应的影响。

Effects of angiotensin II on human endothelial cells survival signalling pathways and its angiogenic response.

作者信息

Kou Baijun, Vatish Manu, Singer Donald R J

机构信息

Clinical Pharmacology, Clinical Science Research Institute, Warwick Medical School, University of Warwick Coventry, CV2 2DX, UK.

出版信息

Vascul Pharmacol. 2007 Oct;47(4):199-208. doi: 10.1016/j.vph.2007.06.011. Epub 2007 Aug 11.

DOI:10.1016/j.vph.2007.06.011
PMID:17804301
Abstract

Reduced capillary density (rarefaction) is an early event of cardiovascular disease. The PI-3K-Akt pathway is a key player in anti-endothelial cells (ECs) apoptosis. VEGF is a key growth factor for angiogenesis. We investigated the effect of Angiotensin II (Ang II) on ECs survival signalling and angiogenesis in vitro. We found that Ang II had a biphasic effect on Akt phosphorylation by western blotting analysis. Low concentration Ang II caused a dose-dependent increase in Akt phosphorylation, while high concentration of Ang II led to a decrease of Akt phosphorylation. This effect was negative regulated by its type II receptor. Ang II 10(-4) M induced ECs apoptosis by its type II receptor was completely blocked by VEGF. Cell viability was increased by Ang II 10(-6) M and decreased by Ang II 10(-4) M. It was further decreased by pre-treatment with PI-3K/Akt inhibitor LY294002, but unaffected by p38-MAPK inhibitor SB202190. Ang II 10(-4) M reduced ECs' proliferation and vascular tube length, which were in part regulated by type II receptor. Our findings support a dose-dependent role of Ang II in effect on ECs survival and angiogenesis by PI-3K/Akt pathway. The anti-angiogenic effect of Ang II was mediated by its type II receptor.

摘要

毛细血管密度降低(稀疏化)是心血管疾病的早期事件。PI-3K-Akt信号通路是抗内皮细胞(ECs)凋亡的关键参与者。血管内皮生长因子(VEGF)是血管生成的关键生长因子。我们研究了血管紧张素II(Ang II)对体外培养的内皮细胞存活信号和血管生成的影响。通过蛋白质免疫印迹分析,我们发现Ang II对Akt磷酸化具有双相作用。低浓度的Ang II导致Akt磷酸化呈剂量依赖性增加,而高浓度的Ang II则导致Akt磷酸化减少。这种作用受到其II型受体的负调控。Ang II 10(-4) M通过其II型受体诱导内皮细胞凋亡,而VEGF可完全阻断该作用。Ang II 10(-6) M可提高细胞活力,而Ang II 10(-4) M则降低细胞活力。用PI-3K/Akt抑制剂LY294002预处理可进一步降低细胞活力,但p38丝裂原活化蛋白激酶(p38-MAPK)抑制剂SB202190对其无影响。Ang II 10(-4) M可降低内皮细胞的增殖和血管管长度,这部分受II型受体调控。我们的研究结果支持Ang II通过PI-3K/Akt信号通路对内皮细胞存活和血管生成具有剂量依赖性作用。Ang II的抗血管生成作用是由其II型受体介导的。

相似文献

1
Effects of angiotensin II on human endothelial cells survival signalling pathways and its angiogenic response.血管紧张素II对人内皮细胞存活信号通路及其血管生成反应的影响。
Vascul Pharmacol. 2007 Oct;47(4):199-208. doi: 10.1016/j.vph.2007.06.011. Epub 2007 Aug 11.
2
Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.血管紧张素II 2型受体抑制血管内皮生长因子诱导的人内皮细胞迁移和体外管腔形成。
Circ Res. 2003 Sep 5;93(5):438-47. doi: 10.1161/01.RES.0000088358.99466.04. Epub 2003 Jul 24.
3
Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.黄嘌呤氧化酶与人内皮细胞血管生成中血管内皮生长因子的相互作用
Microcirculation. 2008 Apr;15(3):251-67. doi: 10.1080/10739680701651495.
4
Angiotensin II regulates phosphoinositide 3 kinase/Akt cascade via a negative crosstalk between AT1 and AT2 receptors in skin fibroblasts of human hypertrophic scars.血管紧张素II通过人增生性瘢痕皮肤成纤维细胞中AT1和AT2受体之间的负性串扰调节磷酸肌醇3激酶/蛋白激酶B级联反应。
Life Sci. 2006 Jun 27;79(5):475-83. doi: 10.1016/j.lfs.2006.01.031. Epub 2006 Mar 7.
5
Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.缺氧诱导有丝分裂因子通过促进内皮细胞的增殖和迁移来增强血管生成。
Exp Cell Res. 2006 Nov 1;312(18):3559-69. doi: 10.1016/j.yexcr.2006.07.024. Epub 2006 Aug 9.
6
Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.酪氨酸磷酸酶SHP-2的抑制在体外和体内均能抑制血管生成。
J Vasc Res. 2008;45(2):153-63. doi: 10.1159/000110081. Epub 2007 Oct 25.
7
Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis.人多能基质细胞条件培养基的血管生成作用可激活缺氧内皮细胞中的PI3K-Akt信号通路,从而抑制细胞凋亡、提高细胞存活率并刺激血管生成。
Stem Cells. 2007 Sep;25(9):2363-70. doi: 10.1634/stemcells.2006-0686. Epub 2007 May 31.
8
Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.低剂量3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂氟伐他汀对肝细胞生长因子诱导的血管生成的刺激作用:p38丝裂原活化蛋白激酶的参与
Hypertens Res. 2008 Nov;31(11):2085-96. doi: 10.1291/hypres.31.2085.
9
Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.内脂素通过Akt和丝裂原活化蛋白激酶激活内皮型一氧化氮合酶,并在体内外改善内皮细胞功能和血管生成:对动脉粥样硬化的转化意义。
Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1440-9. doi: 10.1152/ajpendo.90780.2008. Epub 2009 Apr 7.
10
Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.骨桥蛋白通过激活内皮细胞中的PI3K/AKT和ERK1/2诱导血管生成。
Oncogene. 2009 Sep 24;28(38):3412-22. doi: 10.1038/onc.2009.189. Epub 2009 Jul 13.

引用本文的文献

1
Disparate biomechanical properties of the aorta in non-aneurysmal and aneurysmal mice treated with angiotensin II.血管紧张素 II 治疗的非动脉瘤和动脉瘤小鼠主动脉的不同生物力学特性。
Physiol Rep. 2022 Sep;10(18):e15410. doi: 10.14814/phy2.15410.
2
Renin-angiotensin system and cancer: epidemiology, cell signaling, genetics and epigenetics.肾素-血管紧张素系统与癌症:流行病学、细胞信号转导、遗传学和表观遗传学。
Clin Transl Oncol. 2021 Apr;23(4):682-696. doi: 10.1007/s12094-020-02488-3. Epub 2020 Sep 15.
3
Atorvastatin reverses the dysfunction of human umbilical vein endothelial cells induced by angiotensin II.
阿托伐他汀可逆转血管紧张素 II 诱导的人脐静脉内皮细胞功能障碍。
Exp Ther Med. 2018 Dec;16(6):5286-5297. doi: 10.3892/etm.2018.6846. Epub 2018 Oct 11.
4
Clinical Perspectives on Targeting Therapies for Personalized Medicine.个性化医疗靶向治疗的临床视角
Adv Protein Chem Struct Biol. 2016;102:79-114. doi: 10.1016/bs.apcsb.2015.11.003. Epub 2015 Dec 29.
5
Synergistic effect of angiotensin II on vascular endothelial growth factor-A-mediated differentiation of bone marrow-derived mesenchymal stem cells into endothelial cells.血管紧张素II对血管内皮生长因子A介导的骨髓间充质干细胞向内皮细胞分化的协同作用。
Stem Cell Res Ther. 2015 Jan 6;6(1):4. doi: 10.1186/scrt538.
6
AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.AT1 受体拮抗作用在大脑中具有促血管生成作用:BDNF 是一种新的介导物。
J Pharmacol Exp Ther. 2013 Feb;344(2):348-59. doi: 10.1124/jpet.112.197483. Epub 2012 Dec 4.
7
Impact of AT2 receptor deficiency on postnatal cardiovascular development.AT2受体缺乏对出生后心血管发育的影响。
PLoS One. 2012;7(10):e47916. doi: 10.1371/journal.pone.0047916. Epub 2012 Oct 29.
8
Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation.血管紧张素 II 诱导的血管生成过程是通过血管内皮生长因子受体-1 的磷酸化由脾酪氨酸激酶介导的。
Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H1043-55. doi: 10.1152/ajpheart.01018.2010. Epub 2011 Jun 3.